Equities

Creo Medical Group PLC

Creo Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)31.00
  • Today's Change-0.25 / -0.80%
  • Shares traded44.19k
  • 1 Year change-4.62%
  • Beta1.1892
Data delayed at least 20 minutes, as of Sep 20 2024 13:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in GBX

The one analyst offering a 12 month price target expects Creo Medical Group PLC share price to rise to 80.00 in the next year from the last price of 31.25.
High156.0%80.00
Med156.0%80.00
Low156.0%80.00

Earnings history & estimates in GBX

Creo Medical Group PLC reported annual 2023 losses of -7.00 per share on May 15, 2024.
Average growth rate+8.56%
More ▼

Revenue history & estimates in GBP

Creo Medical Limited had revenues for the full year 2023 of 30.80m. This was 13.36% above the prior year's results.
Average growth rate+39.55%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.